Compare SATL & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SATL | CTKB |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.2M | 541.1M |
| IPO Year | 2021 | 2021 |
| Metric | SATL | CTKB |
|---|---|---|
| Price | $6.01 | $5.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $5.50 | ★ $5.63 |
| AVG Volume (30 Days) | ★ 4.3M | 1.1M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $17,707,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $88.89 | $5.42 |
| Revenue Next Year | $56.98 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 37.58 | 17.67 |
| 52 Week Low | $1.26 | $3.31 |
| 52 Week High | $12.00 | $6.18 |
| Indicator | SATL | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 61.71 | 71.54 |
| Support Level | $5.90 | $4.17 |
| Resistance Level | $6.84 | $6.04 |
| Average True Range (ATR) | 0.42 | 0.25 |
| MACD | 0.12 | 0.08 |
| Stochastic Oscillator | 80.23 | 86.81 |
Satellogic Inc is a vertically integrated Earth observation company that designs, manufactures, and operates satellite systems, delivering decision-grade insights at scale to government and commercial customers. Through an end-to-end production and operations model, it provides governments with flexible options across their journey toward sovereign Earth observation. From access to high-frequency imagery and managed space systems to full satellite ownership, to supporting autonomous data availability and long-term technological independence. It has monitoring and alert-driven workflows that help defense and intelligence agencies, civil governments, and commercial operators transition from reactive tasking to proactive decision-making, providing mission-critical data when needed.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.